1
News Release
Notice regarding the Allotment of Share Warrants
as Stock Compensation-Type Stock Options
May 17, 2018 – Sekisui House, Ltd. (“the Company”) hereby announces that at the meeting of
the Board of Directors held today the Company resolved the details of offering for stock
compensation-type stock options to be issued to directors and executive officers of the Company
in accordance with Articles 236, 238 and 240 of the Companies Act.
1. Reasons for issuance of stock compensation-type stock options
The Company has abolished the retirement benefit system for directors and executives officers,
which was principally seniority-based, but has introduced stock compensation-type stock
options since 2006. With the new compensation system, the Company issues stock warrants to
directors and executive officers of the Company as stock compensation-type stock options, while
the amount to be paid in upon exercise of each share warrant will be one yen per share. The
purpose is to enhance the motivation and morale of directors and executive officers in terms of
raising the stock price and improving business performance by strengthening the link between
the compensation system for directors and executive officers and the Company’s stock price or
business performance, and by having directors and executive officers share not only the merits
of an increase in the stock price, but also the risks of a decline in the stock price with the
shareholders.
2. Outline of issuance of share warrants
(1) Name of share warrants
No. 13 share warrants issuance (Stock compensation-type stock options)
(2) Total number of share warrants
69 units
The above number is the expected number of allotment. If the total number of share warrants is
less than expected, such as in the case where no application was made, allotted total number of
share warrants shall be deemed as the total number of share warrants.
(3) Type and number of shares to be issued upon exercise of share warrants
Type of shares to be issued upon exercise of share warrants shall be the common stock of the
Company. The number of shares to be issued upon exercise of each share warrant shall be
1,000.
Regardless of the above, if the Company conducts a stock split (including an allotment of the
Company’s common stock without receipt of monetary consideration) or a stock consolidation,
the Company shall adjust the number of shares to be issued upon exercise of each share
2
warrant in accordance with the following equation.
Number of shares after the adjustment = Number of shares before the adjustment
× stock split or stock consolidation ratio
The number of shares after the adjustment shall be applied, in the case of a stock split, after the
day following the record date of the stock split, or in the case of a stock consolidation, after the
effective date of the said stock consolidation. However, when a stock split is made under the
condition that a proposal to increase the capital or the reserve by reducing the surplus shall be
approved at the Company’s general meeting of shareholders, and if a date prior to the closing of
the said general meeting of shareholders is set as the record date for the stock split, the number
of shares after the adjustment shall become retroactively applicable on the day following the
said record date, which procedure may be conducted after the day following the closing date of
the said general meeting of shareholders.
Other than the above, if an inevitable need arises after the date of issuance, the Company shall
adjust the number of shares to be issued upon exercise of each share warrant as appropriate
and to the extent reasonable.
Fractional number less than one share after the adjustment shall be truncated.
When adjusting the number of shares to be issued the Company shall, on or before the date
immediately prior to the day on which the number of shares to be issued will be adjusted, send
notice or otherwise publicly announce the relevant details to each person holding share
warrants as provided in the register of share warrants (“Share Warrants Holder”). However, if
notice or announcement cannot be made on or before the date immediately prior to the
applicable adjustment date, notice or announcement shall be issued promptly thereafter.
(4) Amount to be paid upon exercise of each share warrant
The amount payable to the Company upon exercise of each share warrant shall be determined
by multiplying one (1) yen, the per-share exercise price, by the number of common shares to be
issued upon exercise of such share warrant.
(5) Exercise period of share warrants
The exercise period of share warrants shall be from June 15, 2018 through June 14, 2038.
(6) Matters concerning the amount of capital stock and capital surplus increased by the
issuance of shares upon exercise of share warrants
(i) The amount of capital stock increased by the issuance of shares upon exercise of share
warrants shall be the amount obtained by multiplying the maximum limit of capital increase,
as calculated in accordance with the provisions of Article 17, paragraph 1 of the Company
Accounting Regulation, by 0.5, and any fraction of less than one (1) yen arising as a result of
such calculation shall be rounded up to the nearest one (1) yen.
3
(ii) The amount of capital surplus increased by the issuance of shares upon exercise of share
warrants shall be the amount obtained by deducting the capital to be increased, as provided
in (i) above, from the maximum limit of capital increase, as also provided in (i) above.
(7) Restriction on the transfer of share warrants
Any transfer of share warrants requires the approval of the Board of Directors of the Company.
(8) Conditions regarding the acquisition of share warrants
The Company shall be able to acquire share warrants without any consideration on the day
which shall be determined by the Board of Directors, if any of the following items (i), (ii), (iii),
(iv) or (v) is approved by shareholders in a general meeting of shareholders, or where a
shareholder approval in a general meeting of shareholders is not necessary, when approved by
the Board of Directors.
(i) Approval of a merger contract pursuant to which the Company shall be a dissolving
company
(ii) Approval of an agreement or a plan for corporate split pursuant to which the Company
shall become a wholly-owned subsidiary of another company
(iii) Approval of a share exchange agreement or a share transfer plan where the Company
shall become a wholly-owned subsidiary of another company
(iv) Approval of an amendment of the Company’s Articles of Incorporation so that any
acquisition by transfer of shares issued by the Company shall require approval of the
Company
(v) Approval of an amendment of the Company’s Articles of Incorporation that would require
an approval of the Company for an acquisition by transfer of shares issued upon exercise
of share warrants, or that would allow the Company to acquire all such shares with the
approval by shareholders in a general meeting of shareholders
(9) Policy regarding cancellation of share warrants in the event of reorganization and issuance
of share warrants of a subject company of reorganization
If the Company conducts a merger (but only when the Company is the dissolving company),
corporate split, share exchange or share transfer (collectively the “corporate reorganization”),
the Company shall grant the persons holding share warrants existing immediately before the
effectiveness of the corporate reorganization (the “existing share warrants”) stock acquisition
rights of the joint stock company as stipulated in Article 236, paragraph 1-8, items (a) to (e) (the
“subject company”) in accordance with the following conditions. In such event, the existing
share warrants shall be canceled and the share warrants of the subject company shall be newly
issued. This only applies in cases where such grant of share warrants is stipulated in the
applicable merger contract, statutory consideration contract, corporate split contract, share
exchange contract or share transfer plan.
(i) The number of share warrants of the subject company to be granted
4
The number of share warrants of the subject company to be granted shall be the same as the
number of existing share warrants.
(ii) The type of shares of the subject company to be issued upon exercise of share warrants
Common stock of the subject company.
(iii) The number of shares of the subject company to be issued upon exercise of share
warrants
It shall be determined following Item 3 above, considering the terms and conditions of the
corporate reorganization.
(iv) Amount to be paid upon exercise of share warrants
The amount payable to the Company upon exercise of share warrants shall be determined by
multiplying one (1) yen, the per-share exercise price of the subject company, by the number of
shares of the subject company to be issued upon exercise of such share warrants as determined
in accordance with (iii) above.
(v) Exercise period of share warrants
The exercise period of share warrants shall begin on the date of commencement of the exercise
period stipulated in Item 5 above or the effective date of the corporate reorganization,
whichever is later, and end on the closing date of the exercise of such share warrants as
determined in accordance with Item 5 above.
(vi) Matters concerning the amount of capital stock and capital surplus increased by the
issuance of the shares upon exercise of share warrants
Shall be determined in accordance with Item 6 above.
(vii) Restriction on the transfer of share warrants
Any transfer of share warrants requires the approval of the Board of Directors of the subject
company.
(viii) Conditions regarding the acquisition of share warrants
Shall be determined in accordance with Item 8 above.
(ix) Additional conditions for the exercise of share warrants
Shall be determined in accordance with Item 11 below.
(10) Treatment of fractional shares upon exercise of share warrants
If fractional portion of shares were to be allotted upon exercise of share warrants, they shall be
disregarded.
(11) Additional conditions for the exercise of share warrants
(i) A Share Warrants Holder may, during the period provided in Item 5 above, exercise their
5
share warrants from the day following the date on which they lose their position as a
director (including corporate officers, in the event that the Company should adopt a
“Company with
Nominating Committees” corporate governance system), statutory
auditor, or executive officer of the Company or its consolidated subsidiaries (such a date is
the “Start of the Exercise Period”).
(ii) Regardless of (i) above, a Share Warrants Holder may exercise share warrants in the
period provided below if either a. or b. occurs (provided that b. shall not apply if share
warrants of the Reorganized Company will be granted to the Share Warrants Holder in
accordance with Item 9 above):
a. If the Start of the Exercise Period does not occur by June 14, 2037
Share warrants may be exercised for the period between June 15, 2037 and June
14, 2038.
b. If a proposal to approve a merger contract, pursuant to which the Company shall
be a dissolving company, or a proposal to approve a share exchange agreement or
a share transfer plan where the Company shall become a wholly-owned
subsidiary of another company, is approved at the Company’s general meeting of
shareholders, or, if such a proposal is approved by the Board of Directors when
approval by the general meeting of shareholders is not necessary.
Share warrants may be exercised for a period of fifteen (15) days from the date
immediately following the relevant approval date.
(iii) If a Share Warrants Holder waives their share warrants, they may not exercise the
relevant share warrants.
(iv) No partial exercise of a single share warrant is allowed.
(v) Other conditions shall be provided by the share warrants granting agreement to be
concluded between the Company and the person to whom share warrants are allotted.
(12) Calculation of the amount to be paid for share warrants
The amount to be paid for share warrants shall be the option price per share calculated based
on the following formula, multiplied by the number of shares to be issued upon exercise of share
warrants.
TdNXedNSeC
rTqT
In this formula,
T
Tqr
X
S
d
2
ln
2
(i)
C
=option price per share
6
(ii)
S
=share price: the regular closing price of the Company’s common stock on the Tokyo
Stock Exchange on June 14, 2018 (or the standard price on the following trading day if
there is no closing price on that date)
(iii)
X
=exercise price: 1 yen
(iv)
T
=expected duration: 10 years
(v)
σ
= volatility: rate of stock price variability, which is calculated based upon the closing
prices of ordinary shares of the Company in the regular trading thereof on the last
trading day of each month in the preceding 10 years (from June 2008 to May 2018)
(vi)
r
= risk-free interest rate: the interest rate on Japanese government bonds for the
remaining years corresponding to the expected duration
(vii)
q
= dividend yield: dividends per share (actual dividends paid for the fiscal year ended
on January 31, 2018) ÷ share price as provided in (ii) above
(viii)
N
(·)=cumulative distribution function of the standard normal distribution
The amount calculated based on the above formula is the fair value of the share warrants. The
Company will pay the person to whom share warrants are allotted monetary compensation
equal to the said amount and offset their rights to request compensation from the Company
against their payment obligations to be paid for the share warrants.
(13) Date of allotment of share warrants
Date of allotment of share warrants shall be June 14, 2018.
(14) Date of payment of consideration in exchange of share warrants
Date of payment of consideration in exchange of share warrants shall be June 14, 2018.
(15) Persons to whom the share warrants are allotted, the number of those persons, and the
number of share warrants to be allotted
38 units of share warrants shall be allotted to 11 directors, and 31 units to 21 executive officers
of the Company.
*** *** ***
For further information, please contact:
Mr. Atsushi Yoshida
Chief Manager of Investor Relations Department
Sekisui House, Ltd.
Email: [email protected]house.co.jp
